KPV: What Researchers Need to Know

September 7, 2026

Research use only: All compounds supplied by Precision Chain Peptides are intended strictly for laboratory and in-vitro research use only. They are not intended for human or animal use.

KPV: What Researchers Need to Know

Buy KPV UK | Research Peptide — KPV is a short tripeptide that has attracted scientific interest for its potential role in inflammatory signalling pathways. This guide explains what KPV is, where it comes from biologically, and what the research literature has found, in plain language designed for readers without a scientific background.

What Is KPV?

KPV is a tripeptide — a chain of just three amino acids: lysine, proline, and valine (hence the abbreviation KPV). It is a fragment derived from alpha-melanocyte-stimulating hormone (alpha-MSH), a naturally occurring peptide hormone that plays a role in a range of biological processes including pigmentation, inflammation, and immune regulation.

Alpha-MSH is a 13-amino-acid peptide, and KPV corresponds to its final three amino acids at the C-terminal end. Research has shown that this short fragment retains some of the biological activity associated with the parent molecule, particularly in relation to inflammatory signalling, which has made it of interest to researchers studying inflammatory biology.

What Does KPV Do Biologically?

KPV is primarily studied for its interactions with inflammatory signalling pathways. Research suggests it may act on receptors and intracellular mechanisms involved in the regulation of inflammatory responses at the cellular level.

Anti-inflammatory signalling. Preclinical research has examined KPV’s effects on pro-inflammatory signalling molecules. Studies in cell culture and animal models have investigated whether KPV can modulate the activity of pathways involved in triggering and sustaining inflammatory responses, including the NF-κB pathway, a key regulator of inflammation-related gene expression.

Cellular interactions. Research has examined how KPV interacts with cells involved in immune and inflammatory responses. Some studies have looked at its effects on macrophages and intestinal epithelial cells, which are cell types relevant to inflammatory processes in various tissues.

Intestinal research. A notable area of KPV research involves intestinal biology. Preclinical studies have examined KPV in models of intestinal inflammation, investigating its effects on inflammatory markers and cellular responses in gut tissue. This has made KPV of interest in the context of gastrointestinal research.

Why Is KPV of Research Interest?

KPV is of research interest for several reasons. As a fragment of alpha-MSH, it provides researchers with a tool to study the mechanisms by which short peptide sequences interact with inflammatory pathways, and to understand which parts of larger peptide hormones are responsible for specific biological activities.

The fact that KPV is a tripeptide — an extremely short peptide — also makes it of interest from a research perspective. Short peptides have different stability, permeability, and interaction profiles compared to larger molecules, and studying them helps researchers understand structure-activity relationships in peptide biology.

Additionally, because inflammatory signalling is relevant to a wide range of biological questions in research, molecules that can modulate these pathways in controlled experimental settings are valuable research tools across multiple fields of study.

What Does the Research Show?

The preclinical research on KPV includes studies in both cell culture systems and animal models. Published work has examined the effects of KPV on inflammatory markers, cellular signalling molecules, and tissue responses in experimental models of inflammation. Some studies have reported that KPV was associated with reductions in pro-inflammatory markers in these experimental settings.

Research in intestinal models has included studies examining KPV’s effects in animal models of colitis, with some preclinical findings reporting effects on intestinal inflammatory parameters. These findings represent laboratory observations in animal models and do not constitute evidence of clinical efficacy in humans.

As with all research peptides, preclinical findings do not automatically translate to outcomes in humans, and the human evidence base for KPV remains very limited. KPV supplied by Precision Chain Peptides is for laboratory and in-vitro research use only and is not intended for human consumption or administration.

Available from Precision Chain Peptides

KPV is available from Precision Chain Peptides as a lyophilised powder for laboratory research use only, dispatched from the UK. All products are manufactured to ≥99% purity, HPLC-verified, and supplied with a batch-specific Certificate of Analysis.

Key Research Terms — Explained Simply

KPV: A tripeptide (lysine-proline-valine) derived from the C-terminal end of alpha-MSH, studied for its interactions with inflammatory signalling pathways
Tripeptide: A peptide consisting of just three amino acids joined by peptide bonds
Alpha-MSH (Alpha-Melanocyte-Stimulating Hormone): A 13-amino-acid peptide hormone involved in pigmentation, inflammation, and immune regulation
NF-κB: A protein complex that acts as a key regulator of inflammation-related gene expression inside cells
Macrophage: A type of immune cell involved in detecting and responding to pathogens and damage, and in regulating inflammatory responses
Intestinal epithelial cells: The cells lining the inner surface of the intestine, which form a barrier and play roles in immune and inflammatory regulation
Pro-inflammatory markers: Molecules produced during an inflammatory response that can be measured to assess the level of inflammation in experimental settings
Preclinical research: Research conducted in laboratory and animal settings, prior to human clinical trials